Contact this trialFirst, we need to learn more about you.
Small Molecule Kinase Inhibitor
Capmatinib +1 More for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Greenwood Village, Colorado
This trial is testing a new combination therapy of drugs to treat lung cancer that has progressed after other treatments. The new therapy will be compared to the standard of care to see if it is more effective.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.